Akseli Hemminki

Person

Helsinki, FI

People

Patents Grantslast 30 patents

Information Patent Grant
Oncolytic adenoviruses coding for bi-specific antibodies
- Patent number 11,485,791
- Issue date Nov 1, 2022
- TILT BIOTHERAPEUTICS OY
- Akseli Hemminki
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Enhanced adoptive cell therapy
- Patent number 10,787,645
- Issue date Sep 29, 2020
- TILT BIOTHERAPEUTICS OY
- Akseli Hemminki
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Enhanced adoptive cell therapy
- Patent number 10,647,963
- Issue date May 12, 2020
- TILT BIOTHERAPEUTICS OY
- Akseli Hemminki
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Recombinant serotype 5 (Ad5) adenoviral vectors
- Patent number 9,410,129
- Issue date Aug 9, 2016
- Targovax Oy
- Tuuli Ranki
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Adenoviral vectors and methods and uses related thereto
- Patent number 9,345,787
- Issue date May 24, 2016
- Targovax Oy
- Akseli Hemminki
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
An oncolytic virus vector coding for interleukin-7 (IL-7) polypeptide
- Publication number 20240398986
- Publication date Dec 5, 2024
- TILT Biotherapeutics Oy
- Tatiana Kudling
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
An oncolytic virus vector coding for variant interleukin-2 (vIL-2)...
- Publication number 20240102047
- Publication date Mar 28, 2024
- TILT Biotherapeutics Oy
- Sadia Zafar
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Oncolytic adenoviruses coding for bi-specific antibodies and method...
- Publication number 20230272108
- Publication date Aug 31, 2023
- TILT Biotherapeutics Oy
- Akseli Hemminki
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Oncolytic adenovirus and checkpoint inhibitor combination therapy
- Publication number 20220251604
- Publication date Aug 11, 2022
- TILT Biotherapeutics Oy
- Akseli Hemminki
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY USING A CHIMERIC ANTIGEN RECEPTOR
- Publication number 20210038659
- Publication date Feb 11, 2021
- Novartis AG
- Carl H. June
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Enhanced adoptive cell therapy
- Publication number 20200399615
- Publication date Dec 24, 2020
- TILT Biotherapeutics Oy
- Akseli Hemminki
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Oncolytic adenoviruses coding for bi-specific antibodies and method...
- Publication number 20180072809
- Publication date Mar 15, 2018
- TILT Biotherapeutics Oy
- Akseli Hemminki
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Enhanced adoptive cell therapy
- Publication number 20170137786
- Publication date May 18, 2017
- TILT Biotherapeutics Oy
- Akseli Hemminki
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ADENOVIRAL VECTORS AND METHODS AND USES RELATED THERETO
- Publication number 20160208287
- Publication date Jul 21, 2016
- TARGOVAX OY
- Akseli Hemminki
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RECOMBINANT SEROTYPE 5 (Ad5) ADENOVIRAL VECTORS
- Publication number 20160082100
- Publication date Mar 24, 2016
- ONCOS THERAPEUTICS OY
- Tuuli RANKI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RECOMBINANT SEROTYPE 5 (Ad5) ADENOVIRAL VECTORS
- Publication number 20150232811
- Publication date Aug 20, 2015
- Oncos Therapeutics Ltd.
- Tuuli Ranki
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Enhanced Adoptive Cell Therapy
- Publication number 20150232880
- Publication date Aug 20, 2015
- TILT Biotherapeutics Oy
- Akseli Hemminki
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ADENOVIRAL VECTORS AND METHODS AND USES RELATED THERETO
- Publication number 20150202324
- Publication date Jul 23, 2015
- ONCOS THERAPEUTICS
- Akseli HEMMINKI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ONCOLYTIC ADENOVIRAL VECTORS AND METHODS AND USES RELATED THERETO
- Publication number 20130323205
- Publication date Dec 5, 2013
- ONCOS THERAPEUTICS OY
- Iulia Diaconu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ONCOLYTIC ADENOVIRAL VECTORS CODING FOR MONOCLONAL ANTI-CTLA-4 ANTI...
- Publication number 20130243731
- Publication date Sep 19, 2013
- ONCOS THERAPEUTICS OY
- Joao Dias
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NON-AD5 ADENOVIRAL VECTORS AND METHODS AND USES RELATED THERETO
- Publication number 20120063995
- Publication date Mar 15, 2012
- ONCOS THERAPEUTICS OY
- Otto Hemminki
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ADENOVIRAL VECTORS AND METHODS AND USES RELATED THERETO
- Publication number 20100166799
- Publication date Jul 1, 2010
- ONCOS THERAPEUTICS
- Akseli HEMMINKI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Akseli Hemminki

Person

Patents Grantslast 30 patents

Oncolytic adenoviruses coding for bi-specific antibodies

Enhanced adoptive cell therapy

Enhanced adoptive cell therapy

Recombinant serotype 5 (Ad5) adenoviral vectors

Adenoviral vectors and methods and uses related thereto

Patents Applicationslast 30 patents

An oncolytic virus vector coding for interleukin-7 (IL-7) polypeptide

An oncolytic virus vector coding for variant interleukin-2 (vIL-2)...

Oncolytic adenoviruses coding for bi-specific antibodies and method...

Oncolytic adenovirus and checkpoint inhibitor combination therapy

COMBINATION THERAPY USING A CHIMERIC ANTIGEN RECEPTOR

Enhanced adoptive cell therapy

Oncolytic adenoviruses coding for bi-specific antibodies and method...

Enhanced adoptive cell therapy

ADENOVIRAL VECTORS AND METHODS AND USES RELATED THERETO

RECOMBINANT SEROTYPE 5 (Ad5) ADENOVIRAL VECTORS

RECOMBINANT SEROTYPE 5 (Ad5) ADENOVIRAL VECTORS

Enhanced Adoptive Cell Therapy

ADENOVIRAL VECTORS AND METHODS AND USES RELATED THERETO

ONCOLYTIC ADENOVIRAL VECTORS AND METHODS AND USES RELATED THERETO

ONCOLYTIC ADENOVIRAL VECTORS CODING FOR MONOCLONAL ANTI-CTLA-4 ANTI...

NON-AD5 ADENOVIRAL VECTORS AND METHODS AND USES RELATED THERETO

ADENOVIRAL VECTORS AND METHODS AND USES RELATED THERETO